| T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse AE Moran, KL Holzapfel, Y Xing, NR Cunningham, JS Maltzman, J Punt, ... Journal of Experimental Medicine 208 (6), 1279-1289, 2011 | 1117 | 2011 |
| Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues KA Casey, KA Fraser, JM Schenkel, A Moran, MC Abt, LK Beura, ... The Journal of Immunology 188 (10), 4866-4875, 2012 | 660 | 2012 |
| The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy AE Moran, M Kovacsovics-Bankowski, AD Weinberg Current opinion in immunology 25 (2), 230-237, 2013 | 202 | 2013 |
| Androgen receptor activity in T cells limits checkpoint blockade efficacy X Guan, F Polesso, C Wang, A Sehrawat, RM Hawkins, SE Murray, ... Nature 606 (7915), 791-796, 2022 | 185 | 2022 |
| Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data D Sun, X Guan, AE Moran, LY Wu, DZ Qian, P Schedin, MS Dai, ... Nature biotechnology 40 (4), 527-538, 2022 | 148 | 2022 |
| T‐cell receptor affinity in thymic development AE Moran, KA Hogquist Immunology 135 (4), 261-267, 2012 | 144 | 2012 |
| Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice AE Moran, DH Hunt, SH Javid, M Redston, AM Carothers, MM Bertagnolli Journal of Biological Chemistry 279 (41), 43261-43272, 2004 | 119 | 2004 |
| Carnosol inhibits β-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+(Min/+) mouse AE Moran, AM Carothers, MJ Weyant, M Redston, MM Bertagnolli Cancer Research 65 (3), 1097-1104, 2005 | 104 | 2005 |
| A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone JN Graff, TM Beer, JJ Alumkal, RE Slottke, WL Redmond, GV Thomas, ... Journal for immunotherapy of cancer 8 (2), 2020 | 89 | 2020 |
| Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin /+ mouse model of colorectal cancer SH Javid, AE Moran, AM Carothers, M Redston, MM Bertagnolli Carcinogenesis 26 (3), 587-595, 2005 | 87 | 2005 |
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy CP Vellano, MG White, MC Andrews, M Chelvanambi, RG Witt, ... Nature 606 (7915), 797-803, 2022 | 60 | 2022 |
| Controlled growth factor release in 3D‐printed hydrogels P Wang, D Berry, A Moran, F He, T Tam, L Chen, S Chen Advanced healthcare materials 9 (15), 1900977, 2020 | 54 | 2020 |
| 3D bioprinting of hydrogels for retina cell culturing P Wang, X Li, W Zhu, Z Zhong, A Moran, W Wang, K Zhang, S Chen Bioprinting 12, e00029, 2018 | 49 | 2018 |
| Pembrolizumab (Pembro) plus enzalutamide (Enz) in metastatic castration resistant prostate cancer (mCRPC): Extended follow up. JN Graff, JJ Alumkal, RF Thompson, A Moran, GV Thomas, MA Wood, ... Journal of Clinical Oncology 36 (15_suppl), 5047-5047, 2018 | 42 | 2018 |
| OX40 agonist tumor immunotherapy does not impact regulatory T cell suppressive function F Polesso, M Sarker, AD Weinberg, SE Murray, AE Moran The Journal of Immunology 203 (7), 2011-2019, 2019 | 36 | 2019 |
| 3D printing of a biocompatible double network elastomer with digital control of mechanical properties P Wang, DB Berry, Z Song, W Kiratitanaporn, J Schimelman, A Moran, ... Advanced functional materials 30 (14), 1910391, 2020 | 35 | 2020 |
| Late-stage tumor regression after PD-L1 blockade plus a concurrent OX40 agonist F Polesso, AD Weinberg, AE Moran Cancer immunology research 7 (2), 269-281, 2019 | 33 | 2019 |
| Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor AM Carothers, AE Moran, NL Cho, M Redston, MM Bertagnolli Cancer research 66 (12), 6432-6438, 2006 | 31 | 2006 |
| A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions LJ Wirth, JF Krane, Y Li, M Othus, AE Moran, DM Dorfman, CM Norris Jr, ... Cancer Prevention Research 1 (5), 339-348, 2008 | 29 | 2008 |
| Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility AM Carothers, SH Javid, AE Moran, DH Hunt, M Redston, MM Bertagnolli Experimental cell research 312 (4), 387-400, 2006 | 28 | 2006 |
